TY - JOUR
T1 - Outcome predictors in the management of spinal myxopapillary ependymoma
T2 - An integrative survival analysis
AU - Kukreja, Sunil
AU - Ambekar, Sudheer
AU - Sharma, Mayur
AU - Sin, Anthony Hunkyun
AU - Nanda, Anil
N1 - Publisher Copyright:
© 2015 Published by Elsevier Inc.
PY - 2015/5/1
Y1 - 2015/5/1
N2 - Objectives The results in earlier studies have described a variable association with age, extent of resection, and radiotherapy (RT) correlating with the survival of myxopapillary ependymomas. The aim of our study is to perform a survival analysis on patient data gathered from a comprehensive review of the literature and determine the influence of these factors on progression-free (PFS) and overall survival (OS). Methods A PubMed search was performed to select the articles containing information about the critical events (recurrence/death), time to events, and treatment characteristics (extent of resection with or without RT) in the patients with spinal myxopapillary ependymomas. Results A total of 337 patients with information regarding the critical events, time to events, and treatment characteristics was selected for the inclusion. Patients in gross-total resection group had better PFS and OS (P = 0.001, P = 0.000 respectively). The patients in older age group (>35 years) had better PFS (P = 0.008). Overall PFS did not improve if RT was combined with surgery compared with surgery alone; however, the adjuvant RT benefitted the patients age ≤35 years. RT dose >50 Gy had significant influence on the PFS (P = 0.034). Conclusion Gross-total resection plays the most important role in improving PFS and OS. Older patients had better PFS; however, the influence of adjuvant RT was significant in younger age groups. A dose of > 50 Gy improves the results, but a randomized controlled study is warranted to arrive at a definite conclusion.
AB - Objectives The results in earlier studies have described a variable association with age, extent of resection, and radiotherapy (RT) correlating with the survival of myxopapillary ependymomas. The aim of our study is to perform a survival analysis on patient data gathered from a comprehensive review of the literature and determine the influence of these factors on progression-free (PFS) and overall survival (OS). Methods A PubMed search was performed to select the articles containing information about the critical events (recurrence/death), time to events, and treatment characteristics (extent of resection with or without RT) in the patients with spinal myxopapillary ependymomas. Results A total of 337 patients with information regarding the critical events, time to events, and treatment characteristics was selected for the inclusion. Patients in gross-total resection group had better PFS and OS (P = 0.001, P = 0.000 respectively). The patients in older age group (>35 years) had better PFS (P = 0.008). Overall PFS did not improve if RT was combined with surgery compared with surgery alone; however, the adjuvant RT benefitted the patients age ≤35 years. RT dose >50 Gy had significant influence on the PFS (P = 0.034). Conclusion Gross-total resection plays the most important role in improving PFS and OS. Older patients had better PFS; however, the influence of adjuvant RT was significant in younger age groups. A dose of > 50 Gy improves the results, but a randomized controlled study is warranted to arrive at a definite conclusion.
KW - Integrative analysis
KW - Myxopapillary spendymoma
KW - Spine
KW - Survival
UR - https://www.scopus.com/pages/publications/84929333613
UR - https://www.scopus.com/inward/citedby.url?scp=84929333613&partnerID=8YFLogxK
U2 - 10.1016/j.wneu.2014.08.006
DO - 10.1016/j.wneu.2014.08.006
M3 - Review article
C2 - 25108296
AN - SCOPUS:84929333613
SN - 1878-8750
VL - 83
SP - 852
EP - 859
JO - World neurosurgery
JF - World neurosurgery
IS - 5
ER -